Earnings estimate revision
Search documents
Strength Seen in PVH (PVH): Can Its 8.4% Jump Turn into More Strength?
ZACKS· 2025-05-15 09:00
Core Viewpoint - PVH Corp's stock has shown significant movement due to an upgrade from Jefferies, highlighting its sales growth potential despite challenges in the operating environment, particularly in China [2] Group 1: Stock Performance - PVH shares increased by 8.4% to $87.28 in the last trading session, with a trading volume higher than average [1] - Over the past four weeks, the stock has gained 17.5% [1] Group 2: Company Strategy - PVH is implementing proactive cost and efficiency measures while focusing on long-term growth, especially in China, through its multi-year PVH+ Plan [3] - The PVH+ Plan is centered around five strategic pillars: product excellence, consumer engagement, digital leadership, data-driven operations, and efficiency-focused investment [3] Group 3: Earnings Expectations - The upcoming quarterly earnings report is expected to show earnings of $2.24 per share, reflecting a year-over-year decline of 8.6%, with revenues projected at $1.93 billion, down 1.1% from the previous year [4] - The consensus EPS estimate for the quarter has been revised 1.6% higher over the last 30 days, indicating a positive trend that may lead to price appreciation [5] Group 4: Industry Context - PVH is part of the Zacks Textile - Apparel industry, where another company, Guess, has seen a 25.7% return in the past month, although it currently holds a Zacks Rank of 4 (Sell) [5][6]
How Much Upside is Left in Altimmune (ALT)? Wall Street Analysts Think 285.86%
ZACKS· 2025-05-09 15:01
Core Viewpoint - Altimmune, Inc. (ALT) shares have increased by 39.4% in the past four weeks, closing at $5.80, with a mean price target of $22.38 indicating a potential upside of 285.9% [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $5.32, where the lowest estimate of $12 suggests a 106.9% increase, and the highest estimate of $28 indicates a potential surge of 382.8% [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about ALT's earnings prospects, as indicated by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 2.3% over the past month, with one estimate increasing and no negative revisions [12] - ALT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13]
How Much Upside is Left in Astrazeneca (AZN)? Wall Street Analysts Think 27.89%
ZACKS· 2025-05-09 15:00
Core Viewpoint - AstraZeneca (AZN) shows potential for further upside, with a mean price target of $86.07 indicating a 27.9% increase from its current price of $67.30 [1] Price Targets and Estimates - The mean estimate consists of 10 short-term price targets with a standard deviation of $10.38, indicating variability among analysts [2] - The lowest estimate is $67, suggesting a 0.5% decline, while the highest estimate is $103, indicating a potential increase of 53.1% [2] - A low standard deviation signifies strong agreement among analysts regarding price movement direction [9] Analyst Sentiment and Earnings Estimates - Analysts exhibit growing optimism about AZN's earnings prospects, as indicated by upward revisions in EPS estimates [11] - Over the past 30 days, two estimates have increased, leading to a 0.2% rise in the Zacks Consensus Estimate [12] - AZN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research shows they rarely predict actual stock price movements [7] - Analysts may set overly optimistic targets due to business incentives, which can inflate price expectations [8] - Investors should approach price targets with skepticism and not rely solely on them for investment decisions [10]
Insights Into Vital Energy (VTLE) Q1: Wall Street Projections for Key Metrics
ZACKS· 2025-05-09 14:20
Core Viewpoint - Analysts project that Vital Energy (VTLE) will report quarterly earnings of $2.11 per share, reflecting a year-over-year increase of 10.5%, with revenues expected to reach $532.28 million, up 10.4% from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has been revised downward by 11.5% over the past 30 days, indicating a collective reassessment by analysts [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Projections - Analysts estimate that 'Revenues- Natural gas' will reach $31.48 million, representing a year-over-year change of +72.6% [5]. - 'Revenues- NGL' are projected to be $59.52 million, indicating a change of +26.4% from the prior-year quarter [5]. - 'Revenues- Oil' are expected to reach $433.52 million, suggesting a year-over-year change of +4.3% [5]. Sales Volumes - The estimated 'Average daily oil equivalent sales volumes' is projected at 139,265.10 BOE/D, compared to 124,719 BOE/D a year ago [6]. - 'Sales volumes - Natural gas' are expected to reach 19,717.95 MMcf, up from 18,534 MMcf in the same quarter last year [7]. - 'Sales volumes - NGL' are forecasted to be 3,426.85 MBBL, compared to 2,934 MBBL a year ago [7]. - 'Sales volumes - Oil' are predicted to reach 5,854.69 MBBL, an increase from 5,327 MBBL in the same quarter last year [8]. Average Sales Prices - The average sales price per Bbl for Oil is estimated at $72.60, down from $78.06 a year ago [8]. - The average sales price per Bbl for NGL is projected at $17.83, compared to $16.05 in the same quarter of the previous year [6]. - The average sales price per Bbl for Oil, including commodity derivatives, is expected to be $75.87, compared to $74.95 in the same quarter last year [9]. Market Performance - Shares of Vital Energy have returned +17.2% over the past month, outperforming the Zacks S&P 500 composite's +13.7% change [10].
Seeking Clues to Integral Ad Science (IAS) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-05-08 14:21
Core Insights - Integral Ad Science (IAS) is expected to report quarterly earnings of $0.03 per share, a 400% increase year-over-year, with revenues projected at $129.66 million, reflecting a 13.2% year-over-year growth [1] Earnings Estimates - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating a collective reevaluation by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts forecast 'Revenue-Optimization revenue' to reach $60.56 million, indicating a year-over-year increase of 15.4% [5] - The consensus for 'Revenue-Publisher revenue' is $19.30 million, suggesting a year-over-year change of 22.2% [5] - The estimate for 'Revenue-Measurement revenue' stands at $49.82 million, reflecting a 7.6% increase from the prior-year quarter [5] Stock Performance - Shares of IAS have shown a return of -1.5% over the past month, contrasting with the Zacks S&P 500 composite's +11.3% change, indicating expected underperformance in the near future [6]
Sally Beauty (SBH) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
ZACKS· 2025-05-08 14:21
Core Insights - Sally Beauty (SBH) is expected to report quarterly earnings of $0.39 per share, an increase of 11.4% year-over-year, with revenues forecasted at $901.1 million, reflecting a decrease of 0.8% compared to the previous year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analysts' projections [1][2] Financial Metrics - Analysts predict 'Net Sales- Sally Beauty Supply' to reach $507.67 million, a year-over-year decline of 1.1% [4] - 'Net Sales- Beauty Systems Group' is expected to be $392.35 million, indicating a decrease of 0.7% from the prior-year quarter [4] - The 'Number of stores at end-of-period - Beauty Systems Group' is projected at 1,329, down from 1,334 in the same quarter last year [5] - The total 'Number of stores at end-of-period' is estimated to be 4,450, compared to 4,468 a year ago [5] - 'Number of stores at end-of-period - Sally Beauty Supply' is forecasted to be 3,121, down from 3,134 in the previous year [6] - 'Operating Income- Beauty Systems Group' is expected to be $49.88 million, an increase from $43.02 million reported in the same quarter last year [6] - 'Operating Income- Sally Beauty Supply' is projected at $83.74 million, up from $76.82 million a year ago [7] Market Performance - Over the past month, shares of Sally Beauty have returned -5.2%, contrasting with the Zacks S&P 500 composite's +11.3% change [8] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [8]
Wall Street Analysts Predict a 56.72% Upside in Upbound Group (UPBD): Here's What You Should Know
ZACKS· 2025-05-06 15:00
Shares of Upbound Group (UPBD) have gained 10.1% over the past four weeks to close the last trading session at $24.17, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $37.88 indicates a potential upside of 56.7%.The average comprises eight short-term price targets ranging from a low of $30 to a high of $50, with a standard deviation of $7.12. While the lowest estimate indicates ...
Stay Ahead of the Game With MercadoLibre (MELI) Q1 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-05-06 14:20
Core Insights - MercadoLibre (MELI) is expected to report quarterly earnings of $7.67 per share, a 13.1% increase year-over-year, with revenues projected at $5.53 billion, reflecting a 27.5% year-over-year growth [1] Earnings Estimates - The consensus EPS estimate has been revised 2.8% lower over the last 30 days, indicating a reevaluation by analysts [2] - Revisions to earnings estimates are crucial for predicting investor actions, as empirical research shows a strong correlation between these revisions and short-term stock price performance [3] Revenue Projections - Analysts estimate 'Revenues- Fintech' to be $2.36 billion, a year-over-year increase of 28.6% [5] - The consensus for 'Revenues- Commerce' is $3.13 billion, indicating a 25.3% increase from the prior-year quarter [5] - 'Geographic Revenue- Argentina' is projected to reach $1.15 billion, reflecting an 87.2% year-over-year change [5] Geographic Revenue Insights - 'Geographic Revenue- Fintech- Argentina' is expected to be $717.87 million, a 73% increase from the year-ago quarter [6] - 'Geographic Revenue- Commerce- Argentina' is forecasted to reach $433.21 million, suggesting a significant year-over-year change of 116.6% [6] Key Metrics - The estimated 'Gross merchandise volume' is $12.95 billion, up from $11.37 billion in the same quarter last year [7] - 'Total payment volume' is projected to be $52.40 billion, compared to $40.73 billion a year ago [7] - MercadoLibre shares have increased by 25.2% in the past month, outperforming the Zacks S&P 500 composite's 11.5% increase [7]
Wall Street's Insights Into Key Metrics Ahead of New York Times (NYT) Q1 Earnings
ZACKS· 2025-05-06 14:20
Core Insights - Wall Street analysts expect New York Times Co. (NYT) to report quarterly earnings of $0.35 per share, reflecting a year-over-year increase of 12.9% [1] - Revenue projections stand at $635.14 million, indicating a 6.9% increase from the previous year [1] Earnings Estimates - The consensus EPS estimate has remained unchanged over the past 30 days, indicating analysts' reassessment of their projections [1][2] Revenue Projections - Digital-only subscription revenues are forecasted to reach $338.94 million, a year-over-year increase of 15.7% [4] - Total digital advertising revenues are expected to be $68.76 million, reflecting a 9.1% increase [4] - Print advertising revenues are projected at $35.24 million, showing a decline of 13.4% from the prior year [4] - Other revenues are estimated at $64.58 million, indicating a 5.3% increase [5] - Print subscription revenues are expected to be $127.62 million, down 6.2% year-over-year [5] - Total advertising revenue is projected at $104.00 million, suggesting a slight increase of 0.3% [5] Subscription Metrics - Subscription revenues are estimated at $466.56 million, reflecting an 8.8% increase from the previous year [6] - Total digital-only subscriptions are projected to reach 11,061, up from 9,910 in the same quarter last year [6] - Print subscriptions are expected to decline to 590, down from 640 in the same quarter last year [7] - Total digital-only ARPU is projected at $9.66, compared to $9.21 a year ago [7] - Total subscriptions for both digital and print are expected to reach 11,651, up from 10,550 in the previous year [7] Market Performance - Over the past month, New York Times shares have returned +14%, outperforming the Zacks S&P 500 composite's +11.5% [8] - The company holds a Zacks Rank 3 (Hold), suggesting performance alignment with the overall market in the near term [8]
Insights Into Western Midstream (WES) Q1: Wall Street Projections for Key Metrics
ZACKS· 2025-05-06 14:20
Analysts on Wall Street project that Western Midstream (WES) will announce quarterly earnings of $0.83 per share in its forthcoming report, representing a decline of 43.5% year over year. Revenues are projected to reach $945.11 million, increasing 6.5% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's ...